News Releases

20240130-vegan-keto-dna-microbes.png

Switching to vegan or ketogenic diet rapidly impacts immune system

January 30, 2024 — NIH study finds distinct immune responses occur quickly when diets change, more research needed to determine health effects.
20240125-coxiella-burnetii.jpg

Researchers create safer form of Coxiella burnetii for scientific use

January 25, 2024 — C. burnetti naturally infects livestock, including goats, sheep and cattle.
20240124-cognitive-behavioral-therapy.jpg

Cognitive behavioral therapy alters brain activity in children with anxiety

January 24, 2024 — NIH researchers found widespread differences in the brains of children with anxiety disorders that improved after treatment.
20240117-hiv.jpg

NIH-developed HIV antibodies protect animals in proof-of-concept study

January 17, 2024 — Findings support the HIV fusion peptide as a promising preventive vaccine target.
20240111-blood-pressure.jpg

Reduced blood lead levels linked to lower blood pressure in American Indians

January 11, 2024 — Reductions correlated with long-term cardiovascular health improvements in NIH-funded study.
202401010-placenta.jpg

NIH-supported researchers create single-cell atlas of the placenta during term labor

January 10, 2024 — Resource informs research on communication between maternal and fetal cells.
202401010-drug-use.jpg

Reduced drug use is a meaningful treatment outcome for people with stimulant use disorders

January 10, 2024 — NIH-supported findings suggest the need to expand definitions of addiction treatment success beyond abstinence.
20240109-rogy-cover.png

A common marker of neurological diseases may play role in healthy brains

January 9, 2024 — NIH-funded research could change how we think about the causes of disorders like Parkinson’s.
20240108-addiction.jpg

Residential addiction treatment for adolescents is scarce and expensive

January 8, 2024 — NIH-supported analysis finds just seven states had a facility that accepted Medicaid, had a bed open the same day, and offered buprenorphine.
20240105-suicidal.jpg

Semaglutide associated with lower risk of suicidal ideations compared to other treatments prescribed for obesity or type 2 diabetes

January 5, 2024 — NIH-funded analysis finds patients treated with semaglutide had 49% to 73% lower risk of suicidal ideation than those given other medications.

ľ��ֱ��

Site Menu

You are here

News & Events

News Releases

20240130-vegan-keto-dna-microbes.png

Switching to vegan or ketogenic diet rapidly impacts immune system

20240125-coxiella-burnetii.jpg

Researchers create safer form of Coxiella burnetii for scientific use

20240124-cognitive-behavioral-therapy.jpg

Cognitive behavioral therapy alters brain activity in children with anxiety

20240117-hiv.jpg

NIH-developed HIV antibodies protect animals in proof-of-concept study

20240111-blood-pressure.jpg

Reduced blood lead levels linked to lower blood pressure in American Indians

202401010-placenta.jpg

NIH-supported researchers create single-cell atlas of the placenta during term labor

202401010-drug-use.jpg

Reduced drug use is a meaningful treatment outcome for people with stimulant use disorders

20240109-rogy-cover.png

A common marker of neurological diseases may play role in healthy brains

20240108-addiction.jpg

Residential addiction treatment for adolescents is scarce and expensive

20240105-suicidal.jpg

Semaglutide associated with lower risk of suicidal ideations compared to other treatments prescribed for obesity or type 2 diabetes

Pages

Connect with Us